A Randomized Controlled Trial of Belimumab for the Treatment of Active Systemic Lupus Erythematosus
Archives of dermatology（2012）
摘要
Commentary on: Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trialNavarra SV, Guzm án RM, Gallacher AE, et al. Lancet. 2011;377(9767):721-731
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要